Wang et al. found that the PKM2 m5C modification regulated by the HIF-1α/ALYREF/PKM2 axis could facilitate bladder cancer progression through the glucose metabolism manner (Wang et al., 2021). Here, ALYREF is linked to urinary bladder cancer.